Weclawiak, Hugo <br/><br/>
Pre-emptive intravenous ganciclovir versus valganciclovir prophylaxis for de novo cytomegalovirus-seropositive kidney-transplant recipients.  [electronic resource] 

 -  Transplant international : official journal of the European Society for Organ Transplantation  Oct 2010 
 - 1056-64 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-2277 
<br/><br/><label>Standard No.: </label>10.1111/j.1432-2277.2010.01101.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Antiviral Agents--therapeutic use<br/>Child<br/>Cohort Studies<br/>Cytomegalovirus--genetics<br/>Cytomegalovirus Infections--prevention & control<br/>DNA, Viral--blood<br/>Female<br/>Ganciclovir--analogs & derivatives<br/>Graft Rejection--prevention & control<br/>Humans<br/>Kidney Transplantation--methods<br/>Male<br/>Middle Aged<br/>Retrospective Studies<br/>Risk Factors<br/>Valganciclovir<br/>Virus Activation